Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
Abroad (travel likely)Recruiting
Conditions
Chronic Migraine · Episodic Migraine · Migraine
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hallym University Dongtan Sacred Heart Hospital /ID# 273581, Hwaseong, Gyeonggido, South Korea
Seoul National University Hospital /ID# 271892, Seoul, Seoul Teugbyeolsi, South Korea
Kangbuk Samsung Hospital /ID# 271893, Seoul, Seoul Teugbyeolsi, South Korea
Yonsei University Health System Severance Hospital /ID# 272639, Seoul, Seoul Teugbyeolsi, South Korea
Study leads
ABBVIE INC.
Study Director
AbbVie